Janney Montgomery Scott
BHVN

Janney Montgomery Scott’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Janney Montgomery Scott’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,454
Closed -$522K – 2690
2022
Q3 		$522K Buy
3,454
+33
+1% +$4.89K ﹤0.01% 1679
2022
Q2 		$497K Buy
3,421
+1,484
+77% +$190K ﹤0.01% 1629
2022
Q1 		$230K Buy
1,937
+67
+4% +$8.36K ﹤0.01% 2017
2021
Q4 		$258K Sell
1,870
-210
-10% -$26.7K ﹤0.01% 2094
2021
Q3 		$289K Buy
+2,080
New +$260K ﹤0.01% 1983

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Janney Montgomery Scott's BHVN Position: Q4 2022 in Review

Janney Montgomery Scott sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 3,454 shares — an estimated $522K sold.

Janney Montgomery Scott first reported a position in BHVN in Q3 2021 and held it in 5 quarters. The position peaked at $522K in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Janney Montgomery Scott reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Janney Montgomery Scott sold 3,454 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $522K.
  • Janney Montgomery Scott first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2021 and held it in 5 quarters.
  • Janney Montgomery Scott's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $522K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Janney Montgomery Scott's 13F filing for Q4 2022, filed 1 Feb 2023.